Identification of a New RXRα Antagonist Targeting the Coregulator-Binding Site.

ABSTRACT: Retinoid X receptor-alpha (RXRα) is implicated in the regulation of many biological processes and also represents a unique intracellular target for pharmacologic interventions. Efforts on discovery of small molecules targeting RXRα have been primarily focused on the molecules that bind to its classical ligand-binding pocket (LBP). Here, we report the identification and characterization of a new RXRα transcriptional antagonist by using structure-based virtual screening. The new antagonist binds with submicromolar affinity to RXRα (K_d = 4.88 × 10^-7 M) and selectively inhibits RXRα transactivation. The compound does not bind to the LBP but to a hydrophobic groove on the surface of RXRα. The new compound also effectively suppresses AKT activation and promotes apopt

SUBMITTER: Chen F 

PROVIDER: S-EPMC4094270 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature